IC
Ikarian Capital Portfolio holdings
AUM
$302M
1-Year Return
65.21%
This Quarter Return
+1.51%
1 Year Return
+65.21%
3 Year Return
+441.33%
5 Year Return
+548.26%
10 Year Return
–
AUM
$268M
AUM Growth
+$159M
(+146%)
Cap. Flow
+$173M
Cap. Flow
% of AUM
64.43%
Top 10 Holdings %
Top 10 Hldgs %
45.87%
Holding
138
New
35
Increased
22
Reduced
7
Closed
15
Top Buys
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
+$21.5M |
| 2 |
Verastem
VSTM
|
+$13.9M |
| 3 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$13.6M |
| 4 |
BioXcel Therapeutics
BTAI
|
+$12M |
| 5 |
Protara Therapeutics
TARA
|
+$10.2M |
Top Sells
| 1 |
APTO
Aptose Biosciences, Inc.
APTO
|
+$5.73M |
| 2 |
KALA BIO
KALA
|
+$4.65M |
| 3 |
Aurinia Pharmaceuticals
AUPH
|
+$3.81M |
| 4 |
TG Therapeutics
TGTX
|
+$3.51M |
| 5 |
ARQL
Arqule Inc
ARQL
|
+$2.97M |
Sector Composition
| 1 | Healthcare | 98% |